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Background
Penile erection is a highly regulated physiologic event in
which the NO-cGMP pathway plays a pivotal role. NO
derived from both non-cholinergic non-adrenergic nerves
and endothelial cells diffuses to the arterial and corporal
smooth muscle cells to bind and activate its target soluble
guanylyl cyclase (sGC). The following increase in cGMP
induces a cascade of events eventually leading to smooth
muscle relaxation and penile erection. Because of its cen-
tral role sGC seems to be an attractive and promising new
target for the treatment of erectile dysfunction. Structur-
ally, sGC is a heterodimer consisting of an α and a β sub-
unit. Of both subunits, two isoforms have been
characterised, however only the sGCα1β1 and sGCα2β1
heterodimers are functionally active.
Materials and methods
In order to elucidate the functional role of the sGCα1β1
heterodimer in the mechanism of erection, experiments
were performed in vivo and on isolated corpora cavernosa
(CC) using sGCα1
-/-  mice. For the in vivo study the
responses to electrical stimulation of the nervus caverno-
sus and intracavernosal injection of different sGC-
dependent and -independent vasodilatory agents were
investigated. For the in vitro study isolated CC tissues
from sGCα1
-/- and sGCα1
+/+ mice were mounted in organ
baths for isometric tension recording and the responses to
different sGC-dependent and -independent vasorelaxing
agents were examined.
Results
The responses in sGCα1
-/- to administration of sodium
nitroprusside (1 – 4 μg/kg or 10-9 – 10-5 mol) and sper-
mine/NO (10 – 20 μg/kg or 10-9 – 10-5 mol) and to elec-
trical stimulation (5 – 15 Hz, 8 V, 60 s or 1 – 8 Hz, 80 V,
20 s) are significantly reduced although not completely
abolished. Responses to sGC-independent vasorelaxing
agents are similar between sGCα1
-/- and sGCα1
+/+ mice
suggesting that the decreased potential of smooth muscle
relaxation is not related to structural changes or changes
in the pathway downstream sGC.
Conclusion
This study clearly illustrates the importance of the
sGCα1β1 heterodimer, however the results also provide
evidence that besides activation of sGCα1β1 also other
mechanisms are involved in penile erection such as
sGCα2β1 and/or sGC-independent mechanisms.
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